Veterinary Medicine Information website

U-tab 2000 mg intrauterine tablet for cattle

Authorised
  • Tetracycline hydrochloride
Download as PDF

Product identification

Medicine name:
U-tab 2000 mg intrauterine tablet for cattle
Active substance:
  • Tetracycline hydrochloride
Target species:
  • Cattle
Route of administration:
  • Intrauterine use

Product details

Active substance and strength:
  • Tetracycline hydrochloride
    2000.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Intrauterine tablet
Withdrawal period by route of administration:
  • Intrauterine use
    • Cattle
      • Meat and offal
        10
        day
      • Milk
        4
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG51AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:
  • (ID4) 10 Intrauterine tablet: Box with 2 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 5 Intrauterine tablet, closed with Foil (aluminium)
  • (ID2) 5 Intrauterine tablet: Box with 1 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) with 5 Intrauterine tablet, closed with Foil (aluminium)
  • (ID3) 20 Intrauterine tablet: Box with 4 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 5 Intrauterine tablet, closed with Foil (aluminium)
  • (ID6) 200 Intrauterine tablet: Box with 40 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 5 Intrauterine tablet, closed with Foil (aluminium)
  • (ID5) 100 Intrauterine tablet: Box with 20 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 5 Intrauterine tablet, closed with Foil (aluminium)
  • (ID1) 50 Intrauterine tablet: Box with 10 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 5 Intrauterine tablet, closed with Foil (aluminium)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Eurovet Animal Health B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Eurovet Animal Health B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 106878
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0140/001
Concerned member states:
  • Austria
  • Netherlands
  • Poland
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 7/02/2022
Download

Summary of Product Characteristics

English (RTF)
Published on: 5/01/2026
Download